Get 20% lifetime commission for referring investors to digrin.com
here.
Heron Therapeutics, Inc. ( HRTX) - Key Metrics
HRTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.20 | -$0.03 | -$0.01 | -$0.01 |
| 2026Q1 | $0.18 | -$0.04 | -$0.01 | -$0.01 |
| 2025Q4 | $0.24 | -$0.02 | -$0.06 | -$0.06 |
| 2025Q3 | $0.22 | -$0.10 | $0.01 | $0.01 |
| 2025Q2 | $0.24 | -$0.02 | -$0.07 | -$0.07 |
HRTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.56 |
| 2026Q1 | 0% | -5.00 |
| 2025Q4 | 0% | -18.90 |
| 2025Q3 | 0% | -3.15 |
| 2025Q2 | 0% | -25.87 |
HRTX
Price: $0.36
52 week price:
Earnings Per Share: -0.19 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4.0 million
Ebitda: -40.9 millionMarket Capitalization: 65.8 million